A stacked pyrazolo­[3,4‐d]­pyrimidine‐based flexible mol­ecule: the effect on stacking of a bulky iso­propyl group in comparison with a methyl/ethyl group

In the crystal structure of 1,3‐bis(4,6‐diiso­propyl­sulfanyl‐1H‐pyrazolo­[3,4‐d]­pyrimidin‐1‐yl)­propane, C₂₅H₃₆N₈S₄, the pairs of pyrazolo­[3,4‐d]­pyrimidine rings in the mol­ecule stack as a result of intramolecular π–π interactions between the heterocyclic rings. The crystal packing also exhibits an intermolecular C—H...π interaction between one methyl group of an iso­propyl group and a pyrazolo­[3,4‐d]­pyrimidine ring.     

Intermolecular stacking in pyrazolo[3,4‐d]pyrimidine‐based pentamethylene‐linked flexible ­molecules

The crystal structures of 1‐{5‐[4,6‐bis­(methyl­sulfanyl)‐2H‐py­razolo­[3,4‐d]­pyrimidin‐2‐yl]­pentyl}‐6‐methyl­sulfanyl‐4‐(pyr­rolidin‐1‐yl)‐1H‐pyrazolo­[3,4‐d]­pyrimidine, C₂₂H₂₉N₉S₃, and 6‐methyl­sulfanyl‐1‐{5‐[6‐methyl­sulfanyl‐4‐(pyrrolidin‐1‐yl)‐2H‐pyrazolo­[3,4‐d]­pyrimidin‐2‐yl]­pentyl}‐4‐(pyrrolidin‐1‐yl)‐1H‐pyrazolo­[3,4‐d]­pyrimidine, C₂₅H₃₄N₁₀S₂, which differ in having either a pyrrolidine substituent or a methylsulfanyl group, show intermolecular stacking due to aromatic π–π interactions between the pyrazolo­[3,4‐d]­pyrimidine rings.     

A stacked pyrazolo[3,4-d]pyrimidine-based flexible molecule: the effect on stacking of an ethyl group in comparison with a methyl group

In the crystal structure of 1,1′-(1,3-propane­diyl)­bis(5-ethyl-6-methyl­thio-4,5-di­hydro-1H-pyrazolo­[3,4-d]­pyrimidin-4-one), C₁₉H₂₄N₈O₂S₂, the pairs of pyrazolo­[3,4-d]­pyrimidine rings of the mol­ecule stack between the heterocyclic rings, due to intramolecular π–π interactions. The substituted ethyl and methyl groups are comparable as far as intramolecular stacking is concerned.     

Disappearance of intramolecular stacking due to one‐atom movement or increment of a `propyl­ene linker' in pyrazolo­[3,4‐d]­pyrimidine‐based ­flexible models

In the crystal structures of 4,6‐di­methyl­thio‐1‐[3‐(4,6‐di­methyl­thio‐2H‐pyra­zolo­[3,4‐d]­py­rimi­din‐2‐yl)­propyl]‐1H‐py­ra­­zolo­[3,4‐d]­py­rimi­dine, C₁₇H₂₀N₈S₄, and 1‐[4‐(4‐meth­oxy‐6‐methyl­thio‐1H‐pyra­zolo­[3,4‐d]py­rimi­din‐1‐yl)­butyl]‐5‐meth­yl‐6‐methyl­thio‐4,5‐di­hydro‐1H‐pyra­zolo­[3,4‐d]py­rimi­din‐4‐one, C₁₈H₂₂N₈O₂S₂, only intermolecular stacking due to aromatic π–π interactions between pyrazolo­[3,4‐d]­pyrimidinerings is present.     

Unusual molecular conformation in dissymmetric propyl­ene‐linker compounds containing pyrazolo­[3,4‐d]­pyrimidine and phthalimide moieties

The crystal structure of 4,6‐bis(methylsulfanyl)‐1‐phthalimidopropyl‐1H‐pyrazolo[3,4‐d]pyrimidine, C₁₈H₁₇N₅O₂S₂, (VI), reveals an unusual folded conformation due to an apparent intramolecular C—H⃛π interaction between the 6‐methyl­­sul­fanyl and phenyl groups. However, the closely related compound 6‐methyl­sulfanyl‐1‐phthalimido­propyl‐4‐(pyrroli­din‐1‐yl)‐1H‐pyrazolo­[3,4‐d]­pyrimidine, C₂₁H₂₂N₆O₂S, (VII), exhibits a fully extended structure, devoid of any intramol­ecular C—H⃛π or π–π interactions. The crystal packing of both mol­ecules involves intermolecular stacking interactions due to aromatic π–π interactions. In addition, (VI) exhibits intermolecular C—H⃛O hydrogen bonding and (VII) exhibits dimerization of the mol­ecules through intermolecular C—H⃛N hydrogen bonding.     

The regioisomeric 1H(2H)‐pyrazolo[3,4‐d]pyrimidine N1‐ and N2‐(2′‐deoxy‐β‐D‐ribofuranosides)

In the title regioisomeric nucleosides, alternatively called 1‐(2‐deoxy‐β‐d ‐erythro‐furan­osyl)‐1H‐pyrazolo­[3,4‐d]­pyrimidine, C₁₀H₁₂N₄O₃, (II), and 2‐(2‐deoxy‐β‐d ‐erythro‐furan­osyl)‐2H‐pyrazolo­[3,4‐d]pyrimidine, C₁₀H₁₂N₄O₃, (III), the conformations of the gly­cosyl­ic bonds are anti [?100.4 (2)° for (II) and 15.0 (2)° for (III)]. Both nucleosides adopt an S‐type sugar pucker, which is C2′‐endo‐C3′‐exo (²T₃) for (II) and 3′‐exo (between ₃E and ⁴T₃) for (III).     

A dimeric layered structure of a 4‐oxo‐4,5‐di­hydro‐1H‐pyrazolo­[3,4‐d]­pyrimidine compound

The title compound, 6‐methyl­sulfanyl‐1‐(3‐phenyl­propyl)‐4,5‐di­hydro‐1H‐pyrazolo­[3,4‐d]­pyrimidin‐4‐one, C₁₅H₁₆N₄OS, crystallizes in space group Pbca, with two mol­ecules of similar structure in the asymmetric unit. The molecular structure shows the absence of intramolecular stacking in the crystalline state, as indicated by earlier ¹H NMR analysis in solution. In addition, the crystal packing reveals the formation of a layered structure, due mainly to intermolecular N—H?O=C hydrogen bonding and arene–arene interactions.     

7‐Vinyl‐8‐aza‐7‐de­aza‐2′‐deoxy­adenosine monohydrate

In the title compound, 4‐amino‐1‐(2‐deoxy‐β‐d ‐eythro‐pento­furan­osyl)‐3‐vinyl‐1H‐pyrazolo­[3,4‐d]­pyrimidine monohydrate, C₁₂H₁₅N₅O₃·H₂O, the conformation of the gly­cosyl bond is anti. The furan­ose moiety is in an S conformation with an unsymmetrical twist, and the conformation at the exocyclic C—C(OH) bond is +sc (gauche, gauche). The vinyl side chain is bent out of the heterocyclic ring plane by 147.5 (5)°. The three‐dimensional packing is stabilized by O—H·O, O—H·N and N—H·O hydrogen bonds.     

A highly functionalized ferrocenyl­pyrazolo­[2,3‐a]­pyridine

The crystal structure of [2‐(4‐bromo­phenyl)‐4‐cyano‐5‐ferrocenyl­pyrazolo­[2,3‐a]­pyridin‐7‐yl]­aceto­nitrile, C₂₆H₁₇N₄FeBr or [Fe(C₅H₅)(C₂₁H₁₂BrN₄)], shows that the pyrazolo­pyridine ring system (PP), the bromo­phenyl ring (BP) and the cyclo­penta­diene ring (Cp) are nearly planar. The PP ring system is twisted out of the plane of the BP and Cp rings by about 20°.     

Three 5H‐indeno­[1,2‐c]­pyridazin‐5‐one derivatives,potent type‐B mono­amine oxidase inhibitors

The structures of three compounds, namely 7‐methoxy‐2‐[3‐(tri­fluoro­methyl)­phenyl]‐9H‐indeno­[1,2‐c]­pyridazin‐9‐one, C₁₉H₁₁F₃N₂O₂, (Id), 6‐methoxy‐2‐[3‐(tri­fluoro­methyl)­phenyl]‐9H‐indeno­[1,2‐c]­pyridazin‐9‐one, C₁₉H₁₁F₃N₂O₂, (IId), and 2‐methyl‐6‐(4,4,4‐tri­fluoro­butoxy)‐9H‐indeno­[1,2‐c]­pyridazin‐9‐one, C₁₆H₁₃F₃N₂O₂, (IIf), which are potent reversible type‐B mono­amine oxidase (MAO‐B) inhibitors, are presented and discussed. Compounds (Id) and (IId) crystallize in a nearly planar conformation. The crystal structures are stabilized by weak C—H⋯O hydrogen bonds. The packing is dominated by π–π stacking interactions between the heterocyclic central moieties of centrosymmetrically related mol­ecules. In compound (IIf), the tri­fluoro­ethyl termination is almost perpendicular to the plane of the ring.     

The molecular and supramolecular structures of four 1,5,6,10b‐tetrahydropyrazolo[1,5‐c]quinazolines

The supramolecular structures of the title compounds, 2‐phenyl‐5‐p‐tolyl‐1,5,6,10b‐tetra­hydro­pyrazolo­[1,5‐c]quinazoline, C₂₃H₂₁N₃, (I), 5‐(4‐bromo­phenyl)‐2‐phenyl‐1,5,6,10b‐tetra­hydro­pyrazolo­[1,5‐c]­quinazoline, C₂₂H₁₈BrN₃, (II), 2‐(4‐chlorophenyl)‐5‐phenyl‐1,5,6,10b‐tetrahydropyrazolo[1,5‐c]quinazoline, C₂₂H₁₈ClN₃, (III), and 5‐(4‐bromo­phenyl)‐2‐(4‐chlorophenyl)‐1,5,6,10b‐tetrahydropyrazolo[1,5‐c]quinazoline, C₂₂H₁₇BrClN₃, (IV), are of two general types. Compounds (I), (II) and (III) form base‐paired dimers via N—H?N hydrogen bonds, where (I) and (II) are isomorphous, while in (IV), there are no conventional hydrogen bonds.     

Supramolecular hydrogen‐bonded hexamers in two 5‐aryl‐3‐methyl‐1‐phenyl‐1,6,7,8‐tetra­hydro­pyrazolo­[3,4‐b][1,4]­diazepines

In both title compounds, i.e. 3‐methyl‐1,5‐di­phenyl‐1,6,7,8‐tetra­hydro­pyrazolo­[3,4‐b][1,4]­diazepine, C₁₉H₁₈N₄, (I), and 5‐(4‐chloro­phenyl)‐3‐methyl‐1‐phenyl‐1,6,7,8‐tetra­hydro­pyra­zolo­[3,4‐b][1,4]­diazepine, C₁₉H₁₇ClN₄, (II), an N—H?N hydrogen bond links six mol­ecules to form an R(30) ring. Compound (I) crystallizes in the R space group and (II) crystallizes in P with three mol­ecules in the asymmetric unit. The mol­ecule of (I) contains a disordered seven‐membered ring.     

Rotenone α‐oxime

The structure determination of the title compound, rotenone α‐oxime [systematic name: 1,2,12,12a‐tetra­hydro‐8,9‐di­meth­oxy‐2‐(1‐methyl­ethenyl)‐[1]­benzo­py­rano­[3,4‐b]­furo­[2,3‐h][1]benzo­pyran‐6(6H)‐one oxime], C₂₃H₂₃NO₆, confirms that the mol­ecule has an approximately V‐shaped structure. One of the rings has a typical cyclo­hexene‐like monoplanar conformation and the central ring adopts a 1,2‐diplanar conformation.     

Three ginkgolide hydrates from Ginkgo biloba L.: ginkgolide A monohydrate,ginkgolide C sesquihydrate and ginkgolide J dihydrate,all determined at 120 K

A low‐temperature structure of ginkgolide A monohydrate, (1R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11aS)‐3‐(1,1‐dimethylethyl)‐hexa­hydro‐4,7b‐di­hydroxy‐8‐methyl‐9H‐1,7a‐epoxymethano‐1H,6aH‐cyclo­penta­[c]­furo­[2,3‐b]­furo­[3′,2′:3,4]­cyclopenta­[1,2‐d]­furan‐5,9,12(4H)‐trione monohydrate, C₂₀H₂₄O₉·H₂O, obtained from Mo Kα data, is a factor of three more precise than the previous room‐temperature determination. A refinement of the ginkgolide A monohydrate structure with Cu Kα data has allowed the assignment of the absolute configuration of the series of compounds. Ginkgolide C sesquihydrate, (1S,2R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11S,11aR)‐3‐(1,1‐di­methyl­ethyl)‐hexa­hydro‐2,4,7b,11‐tetrahydroxy‐8‐methyl‐9H‐1,7a‐epoxy­methano‐1H,6aH‐cyclopenta­[c]­furo­[2,3‐b]­furo­[3′,2′:3,4]­cyclo­penta­[1,2‐d]­furan‐5,9,12(4H)‐trione sesquihydrate, C₂₀H₂₄O₁₁·1.5H₂O, has two independent diterpene mol­ecules, both of which exhibit intramolecular hydrogen bonding between OH groups. Ginkgolide J dihydrate, (1S,2R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11aS)‐3‐(1,1‐di­methyl­ethyl)‐hexa­hydro‐2,4,7b‐tri­hydroxy‐8‐methyl‐9H‐1,7a‐epoxy­methano‐1H,6aH‐cyclo­penta­[c]­furo­[2,3‐b]furo[3′,2′:3,4]­cyclo­penta­[1,2‐d]­furan‐5,9,12(4H)‐trione dihydrate, C₂₀H₂₄O₁₀·2H₂O, has the same basic skeleton as the other ginkgolides, with its three OH groups having the same configurations as those in ginkgolide C. The conformations of the six five‐membered rings are quite similar across ­ginkgolides A–C and J, except for the A and F rings of ginkgolide A.     

catena‐Poly­[[[cis‐bis(1‐phenyl­tetra­zole‐κN4)copper(II)]‐di‐μ‐chloro] hemi(1‐phenyl­tetrazole)]

The title compound, {[CuCl₂(PhTz)₂]·0.5PhTz}_n (PhTz is 1‐­phenyl­tetrazole, C₇H₆N₄), has a polymeric structure, with uncoordinated disordered PhTz mol­ecules in the cavities. The coordination polyhedron of the Cu atom is a highly elongated octahedron. The equatorial positions are occupied by two Cl atoms [Cu—Cl = 2.2687 (9) and 2.2803 (7) Å] and two N atoms of the PhTz ligands [Cu—N = 2.0131 (19) and 2.0317 (18) Å]. The more distant axial positions are occupied by two Cl atoms [Cu—Cl = 3.0307 (12) and 2.8768 (11) Å] that lie in the equatorial planes of two neighbouring Cu octahedra. The [CuCl₂(PhTz)₂] units are linked by Cu—Cl bridges into infinite chains extending parallel to the a axis. The chains are linked into two‐dimensional networks by intermolecular C—H⋯N interactions between the phenyl and tetrazole fragments, and by face‐to‐face π–π interactions between symmetry‐related phenyl rings. These two‐dimensional networks, which lie parallel to the ac plane, are connected by intermolecular π–π stacking interactions between phenyl rings, thus forming a three‐dimensional network.     

The mononuclear cobalt(II) complex CoII(DMBDIZ)2(NCS)2, where DMBDIZ is 2,6‐di­methyl­benzo[1,2‐d:4,5‐d′]­di­imidazole

In the title mononuclear cobalt complex, bis(2,6‐di­methyl‐1H,7H‐benzo­[1,2‐d:4,5‐d′]­di­imidazole‐κN³)­bis­(thio­cyanato‐κN)cobalt(II), [Co^II(NCS)₂(DMBDIZ)₂] or [Co(NCS)₂(C₁₀H₁₀N₄)₂], the cobalt(II) ion is coordinated to four N atoms, from two thio­cyanate anions and two DMBDIZ ligands, in a distorted tetrahedral geometry. In the DMBDIZ ligand, the two imine N atoms are positioned cis with respect to one another. The crystal packing of the complex is dominated by both hydrogen bonding, involving two N—H?N and two N—H?S interactions, and aromatic π–π stacking.     

trans‐Di­aqua­bis(5‐carboxy‐1H‐imidazole‐4‐carboxyl­ato‐κ2N3,O4)­cobalt(II) 4,4′‐bi­pyridine solvate

In the title compound, [Co(C₅H₃N₂O₄)₂(H₂O)₂]·C₁₀H₈N₂, the Co atom is trans‐coordinated by two pairs of N and O atoms from two monoanionic 4,5‐di­carboxy­imidazole ligands, and by two O atoms from two coordinated water mol­ecules, in a distorted octahedral geometry. The 4,4′‐bi­pyridine solvent molecule is not involved in coordination but is linked by an N—H⋯N hydrogen bond to the neutral [Co(C₅H₃N₂O₄)₂(H₂O)₂] mol­ecule. Both mol­ecules are located on inversion centers. The crystal packing is stabilized by N—H⋯N and O—H⋯O hydrogen bonds, which produce a three‐dimensional hydrogen‐bonded network. Offset π–π stacking interactions between the pyridine rings of adjacent 4,4′‐bi­pyridine molecules were observed, with a face‐to‐face distance of 3.345 (1) Å.     

A mixed crystal of imperatorin and phellopterin,with C—H...O,C—H...π and π–π interactions

The crystal structure of 9‐(3‐methyl­but‐2‐enyl­oxy)­‐7H‐furo­[3,2‐g]­chro­men‐7‐one–4‐methoxy‐9‐(3‐methyl­but‐2‐enyl­oxy)‐7H‐­furo­[3,2‐g]­chromen‐7‐one (0.926/0.074), 0.926C₁₆H₁₄O₄·0.074C₁₇H₁₆O₅, is characterized by two independent imperatorin mol­ecules in the asymmetric unit, which exhibit different side‐chain conformations. A small amount of phellopterin overlaps with one of the two imperatorin mol­ecules. The supramol­ecular structure is supported by C—H...O, C—H...π and π–π interactions.     

1,N6‐Etheno derivative of 7‐de­aza‐2,8‐di­aza­adenosine

In the tricyclic nucleoside 7‐(β‐d ‐ribo­furan­osyl)‐7H‐imidazo­[1,2‐c]­pyrazolo­[4,3‐e][1,2,3]­triazine, C₁₁H₁₂N₆O₄, the con­formation of the N‐gly­cosyl bond is intermediate between anti and high anti [χ = −103.5 (3)°]. The ribo­furan­ose moiety adopts a ₃T² sugar pucker (S‐type sugar) and the conformation at the exocyclic C—C bond is ap (gauche–trans). Molecules of the title compound form a three‐dimensional network via three medium–strong intermolecular hydrogen bonds (one O—H⋯N and two O—H⋯O bonds).     

An anthracene dimer with a fused 1,3‐dithiole ring at 193 K

The first butterfly‐shaped anthracene dimer including S atoms,8,9‐di­hydro‐3a,8[1′,2′]:9,13b[1′′,2′′]­di­benzeno­dibenzo­[3,4:7,8]cyclo­octa­[1,2‐d]‐1,3‐di­thiole, C₂₉H₂₀S₂, contains an exceptionally long Csp³—Csp³ bond of 1.672 (2) Å in the fused 1,3‐di­thiole ring. The length of the other bond bridging the anthracene moieties is 1.604 (3) Å.